Trial
NCT01061671
Simvastatin Therapy for Moderate and Severe COPD
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Minnesota
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health Research (CIHR); Ottawa Hospital Research Institute
Condition
Pulmonary Disease, Chronic Obstructive
Intervention
simvastatin
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-02